Kit for detecting pepsinogen II
A pepsinogen and kit technology, which is applied in measurement devices, instruments, scientific instruments, etc., can solve the problems of poor sensitivity, small amount of detection samples, and long measurement time, and achieves both detection sensitivity and linear range. Effects of specificity, improved stability and sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] This embodiment provides a kit for detecting pepsinogen II, including reagent R1 and reagent R2; reagent R1 is composed of the following components: phosphate buffer 150mmol / L, Tris-HCl buffer 50mmol / L , Triton X-100 1g / L, polyethylene glycol 6000 8g / L and Proclinc 300 0.5g / L, the concentration of components in reagent R1 is the final concentration of components in reagent R1; reagent R2 is composed of the following concentrations Composition: phosphate buffer 150mmoL / L, glycerin 80g / L, calf serum albumin 20g / L, anti-human pepsinogen II antibody latex solution 1.5g / L and Proclinc-300 0.5g / L, reagent R2 The component concentration is the final concentration of the component in reagent R2.
[0031] The above-mentioned anti-human pepsinogen II antibody latex solution is prepared by the following method:
[0032] S1) Get 3mL of carboxylated latex microsphere solution, dilute to 6mL with phosphate buffer; The mass percent of carboxylated latex microspheres is 5%;
[0033]...
Embodiment 2
[0038] This embodiment provides a kit for detecting pepsinogen II, including reagent R1 and reagent R2; reagent R1 is composed of the following components: phosphate buffer 150mmol / L, Tris-HCl buffer 50mmol / L , Triton X-100 1g / L, polyethylene glycol 6000 8g / L and Proclinc 300 0.5g / L, the concentration of components in reagent R1 is the final concentration of components in reagent R1; reagent R2 is composed of the following concentrations Composition: phosphate buffer 150mmoL / L, trehalose 80g / L, calf serum albumin 20g / L, anti-human pepsinogen II antibody latex solution 1.5g / L and Proclinc-300 0.5g / L, reagent R2 The middle component concentration is the final concentration of the component in reagent R2.
[0039] The above-mentioned anti-human pepsinogen II antibody latex solution is prepared by the following method:
[0040] S1) Get 3mL of carboxylated latex microsphere solution, dilute to 6mL with phosphate buffer; The mass percent of carboxylated latex microspheres is 5%; ...
Embodiment 3
[0046] This embodiment provides a kit for detecting pepsinogen II, including reagent R1 and reagent R2; reagent R1 is composed of the following components: MOPS-NaOH buffer solution 10mmoL / L, Tween 20 0.01g / L , polyethylene glycol 80005g / L and sodium azide 0.05g / L, the component concentration in the reagent R1 is the final concentration of the component in the reagent R1; the reagent R2 is composed of the following components: MOPS-NaOH buffer solution 160mmoL / L, sucrose 10g / L, casein 5g / L, anti-human pepsinogen II antibody latex solution 0.5g / L and sodium azide 0.05g / L, the concentration of components in reagent R2 is the final concentration of components in reagent R2 .
[0047] The above-mentioned anti-human pepsinogen II antibody latex solution is prepared by the following method:
[0048] S1) Get 3mL carboxylated latex microsphere solution, dilute to 6mL with phosphate buffer; Carboxylated latex microsphere is polystyrene latex microsphere, the particle diameter of carb...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka-patsnap-com.libproxy1.nus.edu.sg/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com